Description
Specifications
- Form: White lyophilized powder
- Standard vial size: 5mg / 10mg
- Purity: ≥99% (HPLC & Mass Spec verified)
- Sequence: GHRH(1-44) analog with N-terminal trans-3-hexenoic acid modification
- Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted
- CAS Number: 218949-48-5
Overview
Tesamorelin is a stabilized 44-amino-acid GHRH analog, distinguished in the research literature for its studied effects on visceral adipose tissue and lipid metabolism, in addition to standard GH-axis activity.
Mechanism & Research Findings
Tesamorelin’s N-terminal modification protects it from DPP-4 enzymatic cleavage, extending its functional half-life relative to native GHRH while preserving full receptor agonism. Beyond its core GHRH receptor activity, Tesamorelin has been widely studied for its selective effect on visceral (rather than subcutaneous) fat depots in metabolic research models, making it a frequently referenced compound in lipodystrophy and body-composition research alongside its endocrine applications.
Research Applications
- GHRH receptor stability/resistance studies
- Visceral adipose tissue and lipid metabolism research
- Metabolic and body-composition preclinical models
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.





Reviews
There are no reviews yet.